| Completed |
: Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
: - Ovarian Neoplasm
- Fallopian Tube Cancer
- Primary Peritoneal
: 2007-02-15
: - Drug: Bevacizumab bevacizumab
|
| Completed |
: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
: - Ovarian Cancer
- Primary Peritoneal Cavity Cancer
: 2006-12-06
: - Biological: carcinoembryonic antigen-expressing measles virus
|
| Terminated |
: Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer
: - Ovarian Cancer
- Peritoneal Cancer
- Fallopian Tube Cancer
: 2006-12-05
: - Drug: Bevacizumab cycle 2 (6 c
|
| Terminated |
: ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
: - Fallopian Tube Neoplasms
- Peritoneal Neoplasms
- Ovarian Neop
: 2006-12-01
: - Drug: ABI-007 80mg/m^2 to 150m
|
| Completed |
: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
: - Leukemia
- Lung Cancer
- Malignant Mesothelioma
: 2006-11-09
: - Biological: WT-1 analog peptide vaccine
- Bi
|
| Completed |
: Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")
: - Ovarian Cancer
- Fallopian Tube Neoplasms
- Peritoneal Neoplas
: 2006-10-19
: - Drug: enzastaurin 1125 mg load
|
| Completed |
: Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
: - Recurrent Fallopian Tube Cancer
- Recurrent Ovarian Epithelial Cancer
-
- Drug: sunitinib malate Given P
|
| Completed |
: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
: - Fallopian Tube Cancer
- Peritoneal Neoplasms
- Ovarian Cancer<
: 2006-09-28
: - Drug: phenoxodiol 400mg phenox
|
| Terminated |
: Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2006-09-06
: - Biological: MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine
|
| Withdrawn |
: Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin
: - Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Can
: 2006-08-29
: - Drug: carboplatin
- Drug: gemcitabine hydroc
|
